Guo Y - Search Results

1

Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway.

Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L. Guo Y, et al. Cancer Manag Res. 2018 Oct 11;10:4371-4380. doi: 10.2147/CMAR.S171126. eCollection 2018. Cancer Manag Res. 2018. Retraction in: Cancer Manag Res. 2022 Dec 21;14:3525-3526. doi: 10.2147/CMAR.S402092 PMID: 30349370 Free PMC article. Retracted.

2

miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer.

Guo Y, Liu H, Zhang H, Shang C, Song Y. Guo Y, et al. Oncol Lett. 2012 Sep;4(3):561-565. doi: 10.3892/ol.2012.775. Epub 2012 Jun 27. Oncol Lett. 2012. PMID: 23741253 Free PMC article.

3

Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma.

Xie D, Shang C, Zhang H, Guo Y, Tong X. Xie D, et al. Among authors: guo y. Med Sci Monit. 2015 Jan 18;21:225-30. doi: 10.12659/MSM.893232. Med Sci Monit. 2015. PMID: 25596753 Free PMC article.

4

Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.

Shang C, Guo Y, Zhang H, Xue YX. Shang C, et al. Among authors: guo y. Cancer Chemother Pharmacol. 2016 Mar;77(3):507-13. doi: 10.1007/s00280-016-2964-3. Epub 2016 Jan 19. Cancer Chemother Pharmacol. 2016. PMID: 26781446

5

Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.

Zhang H, Guo Y, Song Y, Shang C. Zhang H, et al. Among authors: guo y. Cancer Chemother Pharmacol. 2017 Jan;79(1):49-55. doi: 10.1007/s00280-016-3194-4. Epub 2016 Nov 22. Cancer Chemother Pharmacol. 2017. PMID: 27878359

6

Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.

Ma Y, Hu X, Shang C, Zhong M, Guo Y. Ma Y, et al. Among authors: guo y. Tumour Biol. 2017 Jul;39(7):1010428317717670. doi: 10.1177/1010428317717670. Tumour Biol. 2017. PMID: 28671055 Free article.

7

Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.

Guo Y, Ma Y, Hu X, Song R, Zhu L, Zhong M. Guo Y, et al. Cancer Biol Ther. 2018 Mar 4;19(3):205-213. doi: 10.1080/15384047.2017.1416276. Epub 2018 Jan 15. Cancer Biol Ther. 2018. PMID: 29281558 Free PMC article.

8

Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.

Qiao X, Liu J, Zhu L, Song R, Zhong M, Guo Y. Qiao X, et al. Among authors: guo y. Int J Med Sci. 2021 Sep 27;18(16):3728-3737. doi: 10.7150/ijms.64253. eCollection 2021. Int J Med Sci. 2021. PMID: 34790046 Free PMC article.

9

METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.

Qiao X, Zhu L, Song R, Shang C, Guo Y. Qiao X, et al. Among authors: guo y. Oral Dis. 2023 Apr;29(3):942-956. doi: 10.1111/odi.14083. Epub 2021 Dec 2. Oral Dis. 2023. PMID: 34807506

10

miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.

Zhang H, Guo Y, Shang C, Song Y, Wu B. Zhang H, et al. Among authors: guo y. Urology. 2012 Dec;80(6):1298-302.e1. doi: 10.1016/j.urology.2012.08.013. Urology. 2012. PMID: 23206776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,131 results

Search Page

Filters